Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China · Delayed Price · Currency is CNY 27.34
+0.14 (0.51%)
Oct 23, 2026, 3:00 PM CST
Jiangsu Sinopep-Allsino Biopharmaceutical Company Description
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China.
The company offers custom peptide synthesis, custom oligo synthesis, conjugate synthesis, FTE, GMP peptides, oligonucleotide NCEs, generic APIs, formulation services, quotation request, research peptide quote, GMP peptide quote, oligonucleotide quote services.
The company was founded in 2009 and is headquartered in Hangzhou, China.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
| Country | China |
| Founded | 2009 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,360 |
| CEO | Ziquan Tong |
Contact Details
Address: No. 1378 Wenyi West Road Hangzhou, 311121 China | |
| Phone | 86 571 8867 1216 |
| Website | sinopep.com |
Stock Details
| Ticker Symbol | 688076 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000051X5 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ziquan Tong | GM and Chairman |
| Wei Ding | Financial Director |
| Xiaohua Li | Senior Vice President |
| Guoqiang Shi | Senior Vice President |
| Zhou Hua | Secretary of Board |
| Dr. Jianjun Jiang Ph.D. | Vice President |